IPO registrations (S-1, F-1) · Registrants
CHEMOKINE THERAPEUTICS CORP
- SEC CIK
- 1092959 · filings on EDGAR ↗
- Registration
- Form S-1, first filed 2008-04-08, last 2008-07-09; 1 initial registration, 1 amendment
- Outcome
- Declared effective 2008-07-14
- Industry (SIC)
- Biological Products, (No Diagnostic Substances) 2836
- Incorporated in
- DE
- Business address
- 1727 WEST BROADWAY SUITE 400, Vancouver, A1 V6J 4S5
- EIN
- 33-0921251
- EDGAR entity type
- operating
- Insiders and CEO pay
- CHEMOKINE THERAPEUTICS CORP on the corporate pages
Offering terms
- Shares offered
- 22,299,654
- Listing
- OTC under the symbol CHKT
Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.
On this site
- Business registration: CHEMOKINE THERAPEUTICS CORP. EXACT (EIN (EXACT, as the state registration reports it))
- SEC filer: CHEMOKINE THERAPEUTICS CORP EXACT (CIK (EXACT))
Filings 3
| Filed | Form | What it is | Name as filed | EDGAR |
|---|---|---|---|---|
| 2008-04-08 | S-1 | S-1 (registration) | CHEMOKINE THERAPEUTICS CORP | 0001176256-08-000453 ↗ |
| 2008-07-09 | S-1/A | S-1/A (amendment) | CHEMOKINE THERAPEUTICS CORP | 0001176256-08-000856 ↗ |
| 2008-07-14 | EFFECT | EFFECT (declared effective) | CHEMOKINE THERAPEUTICS CORP | 9999999995-08-002182 ↗ |
Prospectus pages read 1
| Filed | Form | Read as | Range | Price | Shares | Proceeds | Listing | Underwriters | What was found | Document |
|---|---|---|---|---|---|---|---|---|---|---|
| 2008-07-09 | S-1/A | registration statement | 22,299,654 | - | OTC CHKT | 0 | primary document; shares headline | document ↗ |
Officers, directors and large holders Forms 3, 4 and 5
| Insider | Role | Title | Filings | Years | On this site |
|---|---|---|---|---|---|
| Evans Michael | Director | 1 | 2006 | ||
| Kurth Matthias C | Director | 1 | 2006 | ||
| Osth John | Director | 1 | 2006 | ||
| Piazza C Richard | Director | 1 | 2006 | ||
| Salari Hassan | Director,Officer; Director,Officer,TenPercentOwner; TenPercentOwner | Chief Scientific Officer; Pres./Chief Scientific Officer; President and CEO | 10 | 2006–2009 | |
| AZAB MOHAMMAD | Director | 1 | 2006 | ||
| Ely Guy | Officer | Chief Medical Officer | 1 | 2006 | |
| JAFFER BASHIR | Director,Officer; Officer | Chief Financial Officer | 5 | 2007–2008 | |
| Huang Bin | Officer | VP Business Development | 1 | 2007 | |
| Byrd Bernard C II | Director | 4 | 2007–2008 | ||
| Kowalchuk George M | Director | 3 | 2007–2008 | ||
| Kuhn Brian | Director | 3 | 2007–2008 | ||
| Bahadori Reza | Director | 2 | 2007–2008 | ||
| Korz Walter | Director,Officer; Officer | President & CEO; Vice President, Drug Dev. | 2 | 2008 | |
| Evans Donald RM | Officer | V.P. Corporate Communications | 3 | 2008 | |
| Wong Donald CK | Officer | V.P. Drug Development | 2 | 2008 | |
| Taylor Edward A. | Director | 2 | 2008 |
Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.
Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.
Also on this site Fuzzy
| Record | Name as filed | Where | Dataset | Matched by |
|---|---|---|---|---|
| Business registration | CHEMOKINE THERAPEUTICS CORP. | CA | State business registries | EIN (EXACT, as the state registration reports it) |
| SEC filer | CHEMOKINE THERAPEUTICS CORP | SEC filers (EDGAR) | CIK (EXACT) |
Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.
Others with the same interests
SIC industry Biological Products, (No Diagnostic Substances), A1 first:
- BioNTech SE 2M
- Immatics N.V. 2M
- Fusion Pharmaceuticals Inc. A6
- CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. AZ
- GENETIC TECHNOLOGIES LTD C3
- MESOBLAST LTD C3
- Ablynx NV C9
- SANGAMO THERAPEUTICS, INC CA
- GENITOPE CORP CA
- ABGENIX INC CA
In other datasets, the same topic (Health) in A1:
- Form D issuer: 1219014 B.C. Ltd. (Form D private offerings)
Interests: Biological Products, (No Diagnostic Substances) · Health